Clarity will have superior prostate imaging products, I have no doubt and potentially prostrate therapy to a degree, but I think there will be different use cases for therapy’s as the market is so large.
TLX isn't a one trick pony, they have about 10 products targeting different cancers eg. TLX kidney imaging product awaiting approval has sensitivity of 86% which is quite high for an imagining product, and I don’t believe it will be superseded in a hurry.
CU6 - Media and Industry News, page-293
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.13 |
Change
0.560(10.1%) |
Mkt cap ! $1.910B | |||
| Open | High | Low | Value | Volume |
| $5.68 | $6.17 | $5.68 | $13.88M | 2.313M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 210 | $6.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.15 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |